Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Yongchang Zhang, MD
CONTACT
Lead
Hunan Province Tumor Hospital
This study aims to explore the efficacy of Anlotinib with or without Immune Checkpoint Inhibitor in Standard Chemo-immunotherapy Failed Advanced NSCLC. The primary endpoint was PFS.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted